BioPharma Dive 2025년 12월 8일 Terns drug shows potential to challenge Novartis’ blockbuster leukemia treatment
BioPharma Dive 2025년 12월 8일 Dyne to seek Duchenne drug approval; Kymera, Wave and Structure shares soar
BioPharma Dive 2025년 12월 5일 Hemophilia gene therapies are struggling on the market, even as innovation soars
BioPharma Dive 2025년 12월 3일 After finding ‘irregularities,’ Bristol Myers to extend key trial of Cobenfy in Alzheimer’s psychosis